UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Editorial: in the era of effective antiviral therapy, long‐term dynamic endoscopic monitoring does not seem to be necessary for all CHB patients with compensated cirrhosis

Alimentary pharmacology & therapeutics, 2023-06, Vol.57 (12), p.1467-1468

2023

Volltextzugriff (PDF)

Serum HBcrAg is better than HBV RNA and HBsAg in reflecting intrahepatic covalently closed circular DNA

Journal of viral hepatitis, 2019-05, Vol.26 (5), p.586-595

2019

Volltextzugriff (PDF)

Progress in mesenchymal stem cell-based therapy for acute liver failure

Stem cell research & therapy, 2018-08, Vol.9 (1), p.227-227, Article 227

2018

Volltextzugriff (PDF)

Molecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis

Frontiers in pharmacology, 2022-02, Vol.13, p.787748-787748

2022

Volltextzugriff (PDF)

Editorial: baseline hepatitis B virus haplotype number may help predict a functional cure in patients with chronic hepatitis B treated with nucleotide analogues

Alimentary pharmacology & therapeutics, 2023-03, Vol.57 (5), p.581-582

2023

Volltextzugriff (PDF)

Editorial: switching to tenofovir alafenamide monotherapy is effective and safe for other nucleos(t)ide analogues‐treated patients with chronic hepatitis B

Alimentary pharmacology & therapeutics, 2022-09, Vol.56 (6), p.1090-1091

2022

Volltextzugriff (PDF)

Quantitative Measurement of Serum HBcrAg Can Be Used to Assess the Feasibility of Safe Discontinuation of Antiviral Therapy for Chronic Hepatitis B

Viruses, 2024-04, Vol.16 (4), p.529

2024

Volltextzugriff (PDF)

Mesenchymal Stem Cell Therapy in Acute Liver Failure

Gut and Liver, 2023, 17(5), , pp.674-683

2023

Volltextzugriff (PDF)

Letter: serum HBV RNA and HBcrAg may help to evaluate safely stopping nucleot(s)ide analogues in patients with HBeAg‐negative chronic hepatitis B and without cirrhosis

Alimentary pharmacology & therapeutics, 2022-10, Vol.56 (7), p.1219-1220

2022

Volltextzugriff (PDF)

Rely to: ‘Optimal drug administration manner would rescue partial virological response in chronic hepatitis B patients with entecavir or tenofovir treatment: Methodological issues’

Journal of viral hepatitis, 2021-01, Vol.28 (1), p.221-222

2021

Volltextzugriff (PDF)

Distribution and factors associated with serum HBV pregenomic RNA levels in Chinese chronic hepatitis B patients

Journal of medical virology, 2021-06, Vol.93 (6), p.3688-3696

2021

Volltextzugriff (PDF)

Serum hepatitis B core-related antigen is a satisfactory surrogate marker of intrahepatic covalently closed circular DNA in chronic hepatitis B

Scientific reports, 2017-03, Vol.7 (1), p.173-173, Article 173

2017

Volltextzugriff (PDF)

Effect of silibinin capsules combined with lifestyle modification on hepatic steatosis in patients with chronic hepatitis B

Scientific reports, 2021-01, Vol.11 (1), p.655-655, Article 655

2021

Volltextzugriff (PDF)

Apolipoprotein A5 alleviates LPS/D-GalN-induced fulminant liver failure in mice by inhibiting TLR4-mediated NF-κB pathway

Journal of translational medicine, 2019-05, Vol.17 (1), p.151-151, Article 151

2019

Volltextzugriff (PDF)

Cell heterogeneity, rather than the cell storage solution, affects the behavior of mesenchymal stem cells in vitro and in vivo

Stem cell research & therapy, 2021-07, Vol.12 (1), p.1-391, Article 391

2021

Volltextzugriff (PDF)

Safety and efficacy of sofosbuvir‐based direct‐acting antiviral regimens for hepatitis C virus genotype 6 in Southwest China: Real‐world experience of a retrospective study

Journal of viral hepatitis, 2019-03, Vol.26 (3), p.316-322

2019

Volltextzugriff (PDF)

The high level of IL-1β in the serum of ACLF patients induces increased IL-8 expression in hUC-MSCs and reduces the efficacy of hUC-MSCs in liver failure

Stem cell research & therapy, 2023-08, Vol.14 (1), p.1-231, Article 231

2023

Volltextzugriff (PDF)

Hepatitis B Core-Related Antigen to Indicate High Viral Load: Systematic Review and Meta-Analysis of 10,397 Individual Participants

Clinical gastroenterology and hepatology, 2021-01, Vol.19 (1), p.46-60.e8

2021

Volltextzugriff (PDF)

Tenofovir monotherapy versus tenofovir plus entecavir combination therapy in HBeAg‐positive chronic hepatitis patients with partial virological response to entecavir

Journal of medical virology, 2020-03, Vol.92 (3), p.302-308

2020

Volltextzugriff (PDF)

Optimal drug administration manner would rescue partial virological response in chronic hepatitis B patients with entecavir or tenofovir treatment

Journal of viral hepatitis, 2020-07, Vol.27 (7), p.731-738

2020

Volltextzugriff (PDF)

Early warning and clinical outcome prediction of acute-onchronic hepatitis B liver failure

世界胃肠病学杂志：英文版, 2015-11 (42), p.11964-11973

En-Qiang Chen Fan Zeng Ling-Yun Zhou Hong Tang

2015

Volltextzugriff (PDF)

Upregulation of microRNA-125b-5p alleviates acute liver failure by regulating the Keap1/Nrf2/HO-1 pathway

Frontiers in immunology, 2022-10, Vol.13, p.988668-988668

2022

Volltextzugriff (PDF)

Satisfactory virological response and fibrosis improvement of sofosbuvir-based regimens for Chinese patients with hepatitis C virus genotype 3 infection: results of a real-world cohort study

Virology journal, 2018-10, Vol.15 (1), p.150-150, Article 150

2018

Volltextzugriff (PDF)

Gender and metabolic differences of gallstone diseases

World journal of gastroenterology : WJG, 2009-04, Vol.15 (15), p.1886-1891

2009

Volltextzugriff (PDF)

The urgency to expand the antiviral indications of general chronic hepatitis B patients

Frontiers in medicine, 2023-05, Vol.10, p.1165891

2023

Volltextzugriff (PDF)

1 – 25 von 736

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(597)
Mit Volltextzugriff
(636)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(434)
Life Sciences & Biomedicine
(307)
Humans
(182)
Male
(130)
Female
(105)
Animals
(81)
Gastroenterology & Hepatology
(79)
Middle Aged
(79)
Physical Sciences
(78)
Adult
(72)
Technology
(62)
Aged
(50)
Chemistry
(47)
Materials Science
(42)
Hepatitis B
(38)
Mice
(37)
Physics
(35)
Materials Science, Multidisciplinary
(34)
Patients
(34)
Treatment Outcome
(33)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

World Journal Of Gastroenterology : Wjg
(18)
World Journal Of Gastroenterology
(16)
Gut And Liver
(11)
Virology Journal
(10)
Chinese Medical Journal
(8)
Hepatitis Monthly
(8)
Plos One
(8)
Wuli Xuebao
(8)
Angewandte Chemie
(7)
Applied Mechanics And Materials
(7)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Editorial: in the era of effective antiviral therapy, long‐term dynamic endoscopic monitoring does not seem to be necessary for all CHB patients with compensated cirrhosis

Serum HBcrAg is better than HBV RNA and HBsAg in reflecting intrahepatic covalently closed circular DNA

Progress in mesenchymal stem cell-based therapy for acute liver failure

Molecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis

Editorial: baseline hepatitis B virus haplotype number may help predict a functional cure in patients with chronic hepatitis B treated with nucleotide analogues

Editorial: switching to tenofovir alafenamide monotherapy is effective and safe for other nucleos(t)ide analogues‐treated patients with chronic hepatitis B

Quantitative Measurement of Serum HBcrAg Can Be Used to Assess the Feasibility of Safe Discontinuation of Antiviral Therapy for Chronic Hepatitis B

Mesenchymal Stem Cell Therapy in Acute Liver Failure

Letter: serum HBV RNA and HBcrAg may help to evaluate safely stopping nucleot(s)ide analogues in patients with HBeAg‐negative chronic hepatitis B and without cirrhosis

Rely to: ‘Optimal drug administration manner would rescue partial virological response in chronic hepatitis B patients with entecavir or tenofovir treatment: Methodological issues’

Distribution and factors associated with serum HBV pregenomic RNA levels in Chinese chronic hepatitis B patients

Serum hepatitis B core-related antigen is a satisfactory surrogate marker of intrahepatic covalently closed circular DNA in chronic hepatitis B

Effect of silibinin capsules combined with lifestyle modification on hepatic steatosis in patients with chronic hepatitis B

Apolipoprotein A5 alleviates LPS/D-GalN-induced fulminant liver failure in mice by inhibiting TLR4-mediated NF-κB pathway

Cell heterogeneity, rather than the cell storage solution, affects the behavior of mesenchymal stem cells in vitro and in vivo

Safety and efficacy of sofosbuvir‐based direct‐acting antiviral regimens for hepatitis C virus genotype 6 in Southwest China: Real‐world experience of a retrospective study

The high level of IL-1β in the serum of ACLF patients induces increased IL-8 expression in hUC-MSCs and reduces the efficacy of hUC-MSCs in liver failure

Hepatitis B Core-Related Antigen to Indicate High Viral Load: Systematic Review and Meta-Analysis of 10,397 Individual Participants

Tenofovir monotherapy versus tenofovir plus entecavir combination therapy in HBeAg‐positive chronic hepatitis patients with partial virological response to entecavir

Optimal drug administration manner would rescue partial virological response in chronic hepatitis B patients with entecavir or tenofovir treatment

Early warning and clinical outcome prediction of acute-onchronic hepatitis B liver failure

Upregulation of microRNA-125b-5p alleviates acute liver failure by regulating the Keap1/Nrf2/HO-1 pathway

Satisfactory virological response and fibrosis improvement of sofosbuvir-based regimens for Chinese patients with hepatitis C virus genotype 3 infection: results of a real-world cohort study

Gender and metabolic differences of gallstone diseases

The urgency to expand the antiviral indications of general chronic hepatitis B patients

Suchergebnisse filtern